Avner Halperin is an entrepreneur and executive in the fields of Digital Health and Big Data Analytics. He is Chairman of the Board at EyeControl – winner of the Genesis Award for significant contribution to helping battle the COVID-19 Pandemic. He also leads the Global ARC Initiative for Sheba Medical Center.
Previously, he was CEO of EarlySense for 15 years - bringing the company from idea stage to over 1,000,000 patients served. Prior to that, Avner was CEO of Emmunet, VP Marketing at Radcom (NASDAQ: RDCM), and R&D team leader at Eldat Communications (acquired by Pricer(PRIC.ST)). Earlier, he was Department Head of an R&D Unit in the Israeli Defence Forces Intelligence Corps where he won the Intelligence Innovation Award.
Avner earned an M.Sc. in Applied Physics from Tel Aviv University and an MBA from the MIT Sloan Fellows Executive MBA Program. He has been teaching courses on Economics and Entrepreneurship in the Hebrew University of Jerusalem and Tel Aviv University. His research papers and 32 US Patents in the field of sensor and data analytics have been cited
over 3,500 times.